Vistin Pharma ASA

NEW
OSL:VISTN (Norway)  
kr 20.3 -0.30 (-1.46%) Jul 15
12.08
P/B:
2.57
Market Cap:
kr 900.20M ($ 93.15M)
Enterprise V:
kr 884.39M ($ 91.52M)
Volume:
5.03K
Avg Vol (2M):
25.30K
Trade In:
Volume:
5.03K
Avg Vol (2M):
25.30K

Vistin Pharma ASA’s share price is kr20.3. Its GF Value is kr25.72. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Vistin Pharma ASA stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: kr20.3 GF Value Price/GF Value
Current kr25.72 0.79
Next FY1 End kr27.53 0.74
Next 12 Month kr30.13 0.67
Next FY2 End kr32.02 0.63
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Vistin Pharma ASA's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between Vistin Pharma ASA's stock price and Operating Cash Flow per share, with a coefficient of 92%. This is followed by a 79% correlation with Earnings without NRI per share and a 71% correlation with Book Value per share. The weakest correlation is observed with Book Value per share, at 63%.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies